首页 >
法规速递
-
Document: Timetable: Post-authorisation measure (PAM) assessed by CAT-2025/9/24
2025-09-25查看详情 > -
Document: European Medicine Agency's data protection notice for the Interactive Regulatory Information System (IRIS)-2025/11/3
2025-11-04查看详情 > -
Document: Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes-2025/12/2
2025-12-03查看详情 > -
国家药监局关于修订异维A酸软胶囊说明书的公告（2026年第2号）-2026/1/6
2026-01-07查看详情 > -
Document: Validation checklist for Type II quality variations-2026/2/10
2026-02-11查看详情 > -
Document: List of withdrawn medicinal products in accordance with Art. 123(4) of the Directive (1 January - 31 December 2025)-2026/3/19
2026-03-20查看详情 > -
国家药监局关于暂停进口、销售和使用Alkaloids Bioactives Private Limited和Alchem International Private Ltd秋水仙碱原料药的公告（2026年第40号）-2026/4/22
2026-04-23查看详情 > -
Document: Standard operating procedure for the contribution to the 3-yearly JIACRA reports-2026/6/4
2026-06-05查看详情 > -
国家药监局药审中心关于发布《成人2型糖尿病药物临床研发技术指导原则》的通告（2023年第10号）-2023/02/21
2023-02-21查看详情 > -
国家药监局关于小柴胡颗粒等3种药品转换为非处方药的公告（2023年第119号）-2023/9/13
2023-09-14查看详情 >
